Immix Biopharma, Inc. IMMX Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
- Immix Biopharma, Inc. (IMMX) reported share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price of $2.33 in Q1 2026.
- How has Immix Biopharma, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price changed year-over-year?
- Immix Biopharma, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price increased by 15.3% year-over-year, from $2.02 to $2.33.
- What is the long-term trend for Immix Biopharma, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
- Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price has grown at a 10.6% compound annual growth rate (CAGR), from $1.33 to $2.2.